{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:49:52Z","timestamp":1792698592025,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106813","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:07:57Z","timestamp":1761365277000},"page":"106813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prognostic significance of oligoclonal bands and their subtypes in relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"104","author":[{"given":"Serkan","family":"Ozakbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7126-1475","authenticated-orcid":false,"given":"Said","family":"Alizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeyye","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1481-151X","authenticated-orcid":false,"given":"Ulvi","family":"Samadzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurbanu Aygunduz","family":"Yapici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ela Simay","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106813_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102382","article-title":"Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis","volume":"45","author":"Akaishi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106813_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104329","article-title":"Status of cerebrospinal fluid oligoclonal bands among patients with multiple sclerosis MS at King Abdulaziz Medical City","volume":"71","author":"Alamri","year":"2023","journal-title":"Mult. Scler. Relat. Disord"},{"key":"10.1016\/j.msard.2025.106813_bib0003","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106813_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"Bosc\u00e1","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106813_bib0005","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2025.106813_bib0006","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2025.106813_bib0007","first-page":"1","article-title":"Concordance rate between oligoclonal bands and the kappa index in patients with suspected multiple sclerosis (MS)","volume":"82","author":"Domingues","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2025.106813_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","article-title":"Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study","volume":"14","author":"Farina","year":"2017","journal-title":"J. Neuroinflammat."},{"key":"10.1016\/j.msard.2025.106813_bib0009","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21037\/atm-21-3073","article-title":"Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review","volume":"11","author":"Jin","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.msard.2025.106813_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94423-x","article-title":"Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study","volume":"11","author":"Karrenbauer","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106813_bib0011","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106813_bib0012","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","article-title":"Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness","volume":"180","author":"Link","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2025.106813_bib0013","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-017-0428-6","article-title":"Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination","volume":"5","author":"Liu","year":"2017","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.msard.2025.106813_bib0014","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106813_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102061","article-title":"Clinically isolated syndrome according to McDonald 2010: intrathecal IgG synthesis still predictive for conversion to multiple sclerosis","volume":"18","author":"Schwenkenbecher","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106813_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrneurol.2013.41","article-title":"The utility of cerebrospinal fluid analysis in patients with multiple sclerosis","volume":"9","author":"Stangel","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2025.106813_bib0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.msard.2025.106813_bib0018","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22508","article-title":"Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis","volume":"70","author":"Tumani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106813_bib0019","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archneur.62.4.574","article-title":"Early differential diagnosis of multiple sclerosis using a new oligoclonal band test","volume":"62","author":"Villar","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2025.106813_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01799","article-title":"IgG Index revisited: diagnostic utility and prognostic value in multiple sclerosis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:34:21Z","timestamp":1784345661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"alternative-id":["S2211034825005553"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106813","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of oligoclonal bands and their subtypes in relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106813"}}